
    
      Animal studies have suggested that prostacyclin may downregulate allergic inflammation, thus
      providing the scientific basis for trials of inhaled prostacyclin agonists such as iloprost
      for the treatment of asthma. This study will examine the tolerability of four times daily
      iloprost on asthma symptoms and pulmonary function over a two week treatment period.
    
  